Manufacturability and functionality assessment of different formats of T-cell engaging bispecific antibodies
T-cell-engaging bispecific antibodies (T-bsAbs) are promising immunotherapies for cancer treatment due to their capability of redirecting T-cells toward destroying tumor cells. Numerous T-bsAb formats have been developed, each with advantages and disadvantages in terms of developability, immunogenic...
Saved in:
Published in | mAbs Vol. 15; no. 1; p. 2231129 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Taylor & Francis
2023
Taylor & Francis Group |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | T-cell-engaging bispecific antibodies (T-bsAbs) are promising immunotherapies for cancer treatment due to their capability of redirecting T-cells toward destroying tumor cells. Numerous T-bsAb formats have been developed, each with advantages and disadvantages in terms of developability, immunogenicity, effector functions, and pharmacokinetics. Here, we systematically compared T-bsAbs produced using eight different formats, evaluating the effect of molecular design of T-bsAbs on their manufacturability and functionality. These eight T-bsAb formats were constructed using antigen-binding fragments (Fabs) and single-chain variable fragments (scFvs) of antibodies linked to the crystallizable fragment (Fc) domain of immunoglobulin G. To ensure a fair comparison of growth and production data, we used recombinase-mediated cassette exchange technology to generate the T-bsAb-producing CHO cell lines. The produced T-bsAbs were assessed for their purification profile and recovery, binding capability, and biological activities. Our findings indicated that the manufacturability of bsAbs was adversely affected with increased number of scFv building blocks, while the functionality was affected by the combination of multiple factors, including the binding affinity and avidity of targeting moieties and the flexibility and geometry of formats. These results provide valuable insights into the impact of the format design on the optimal production and function of T-bsAbs. |
---|---|
AbstractList | T-cell-engaging bispecific antibodies (T-bsAbs) are promising immunotherapies for cancer treatment due to their capability of redirecting T-cells toward destroying tumor cells. Numerous T-bsAb formats have been developed, each with advantages and disadvantages in terms of developability, immunogenicity, effector functions, and pharmacokinetics. Here, we systematically compared T-bsAbs produced using eight different formats, evaluating the effect of molecular design of T-bsAbs on their manufacturability and functionality. These eight T-bsAb formats were constructed using antigen-binding fragments (Fabs) and single-chain variable fragments (scFvs) of antibodies linked to the crystallizable fragment (Fc) domain of immunoglobulin G. To ensure a fair comparison of growth and production data, we used recombinase-mediated cassette exchange technology to generate the T-bsAb-producing CHO cell lines. The produced T-bsAbs were assessed for their purification profile and recovery, binding capability, and biological activities. Our findings indicated that the manufacturability of bsAbs was adversely affected with increased number of scFv building blocks, while the functionality was affected by the combination of multiple factors, including the binding affinity and avidity of targeting moieties and the flexibility and geometry of formats. These results provide valuable insights into the impact of the format design on the optimal production and function of T-bsAbs. ABSTRACTT-cell-engaging bispecific antibodies (T-bsAbs) are promising immunotherapies for cancer treatment due to their capability of redirecting T-cells toward destroying tumor cells. Numerous T-bsAb formats have been developed, each with advantages and disadvantages in terms of developability, immunogenicity, effector functions, and pharmacokinetics. Here, we systematically compared T-bsAbs produced using eight different formats, evaluating the effect of molecular design of T-bsAbs on their manufacturability and functionality. These eight T-bsAb formats were constructed using antigen-binding fragments (Fabs) and single-chain variable fragments (scFvs) of antibodies linked to the crystallizable fragment (Fc) domain of immunoglobulin G. To ensure a fair comparison of growth and production data, we used recombinase-mediated cassette exchange technology to generate the T-bsAb-producing CHO cell lines. The produced T-bsAbs were assessed for their purification profile and recovery, binding capability, and biological activities. Our findings indicated that the manufacturability of bsAbs was adversely affected with increased number of scFv building blocks, while the functionality was affected by the combination of multiple factors, including the binding affinity and avidity of targeting moieties and the flexibility and geometry of formats. These results provide valuable insights into the impact of the format design on the optimal production and function of T-bsAbs. |
Author | Mahfut, Farouq Bin Huang, Yuhan Lam, Kong Peng Xu, Shengli Yang, Yuansheng Chen, Serene W Zhang, Wei Loh, Han Ping Huo, Jianxin |
Author_xml | – sequence: 1 givenname: Han Ping surname: Loh fullname: Loh, Han Ping organization: Bioprocessing Technology Institute (BTI), Agency for Science, Technology and Research (ASTAR), Singapore, Singapore – sequence: 2 givenname: Farouq Bin surname: Mahfut fullname: Mahfut, Farouq Bin organization: Bioprocessing Technology Institute (BTI), Agency for Science, Technology and Research (ASTAR), Singapore, Singapore – sequence: 3 givenname: Serene W surname: Chen fullname: Chen, Serene W organization: Bioprocessing Technology Institute (BTI), Agency for Science, Technology and Research (ASTAR), Singapore, Singapore – sequence: 4 givenname: Yuhan surname: Huang fullname: Huang, Yuhan organization: Singapore Immunology Network (SIGN), Agency for Science, Technology and Research (ASTAR), Singapore, Singapore – sequence: 5 givenname: Jianxin surname: Huo fullname: Huo, Jianxin organization: Singapore Immunology Network (SIGN), Agency for Science, Technology and Research (ASTAR), Singapore, Singapore – sequence: 6 givenname: Wei surname: Zhang fullname: Zhang, Wei organization: Bioprocessing Technology Institute (BTI), Agency for Science, Technology and Research (ASTAR), Singapore, Singapore – sequence: 7 givenname: Kong Peng surname: Lam fullname: Lam, Kong Peng organization: Microbiology and Immunology, Singapore, Singapore – sequence: 8 givenname: Shengli surname: Xu fullname: Xu, Shengli organization: Physiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore – sequence: 9 givenname: Yuansheng orcidid: 0000-0002-0026-7069 surname: Yang fullname: Yang, Yuansheng organization: Bioprocessing Technology Institute (BTI), Agency for Science, Technology and Research (ASTAR), Singapore, Singapore |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/37403264$$D View this record in MEDLINE/PubMed |
BookMark | eNpVkU1v1DAQhi1URD_oTwDlyCWLv-I4J4QqoJWKuJSzNbHHwVViL3aC1H9Pwm5X1Bd7Xs88Hs97Sc5iikjIO0Z3jGr6kXWSU634jlMudpwLxnj3ilxsek11S89OZ8XPyXUpj3RbLWUtfUPORSup4EpekPE7xMWDnZcMfRjD_FRBdJVfop1DinBQSsFSJoxzlXzlgveYt8CnPMFcNvGhtjiOFcYBhhCHqg9ljzb4YFfeHPrkApa35LWHseD1cb8iP79-ebi5re9_fLu7-XxfW9nquVaOKi5407TQdNgo8Nr2lkPX9nJNYLbXTHnXSsEk7VRnGaoGpfTKWSFtJ67I3YHrEjyafQ4T5CeTIJh_QsqDgTwHO6LRrqNWSqdoB1IhaokSmVQeoV-bcCvr04G1X_oJnV3_nWF8AX15E8MvM6Q_hq0TlrKhK-HDkZDT7wXLbKZQtmlBxLQUw7UQSupWqDW1OaTanErJ6E_vMGo2582z82Zz3hydX-ve_9_kqerZZ_EXRUWs5w |
CitedBy_id | crossref_primary_10_1080_19420862_2024_2330113 |
Cites_doi | 10.1074/jbc.M117.793497 10.1136/jitc-2021-003114 10.1016/j.ccell.2017.02.001 10.1021/bi00209a003 10.1016/S0006-3495(00)76602-1 10.1371/journal.pone.0051817 10.1016/S1470-2045(22)00335-7 10.1093/protein/gzp077 10.1093/abt/tbac025 10.3389/fcell.2019.00370 10.1016/j.ymeth.2018.08.008 10.1016/j.ymeth.2018.10.005 10.1016/j.ymeth.2018.10.006 10.1007/s13238-017-0429-z 10.1371/journal.pone.0063247 10.1080/19420862.2019.1574521 10.1007/s40265-022-01793-1 10.2147/CPAA.S42689 10.1016/j.ymeth.2018.10.026 10.1080/2162402X.2016.1168557 10.1007/s40259-018-0299-9 10.1016/j.chroma.2019.04.012 10.4161/19420862.2015.989013 10.1093/protein/9.7.617 10.1016/j.drudis.2015.02.008 10.1186/s13045-015-0227-0 10.1002/biot.201700175 10.1155/2012/980250 10.1038/sj.bjc.6601759 10.1126/scitranslmed.aat5775 10.1074/jbc.M114.620260 10.1073/pnas.1019002108 10.1073/pnas.1719905115 10.1016/S1389-0344(01)00066-1 10.1002/jps.21104 10.1200/JCO.2020.38.6_suppl.TPS261 10.1074/jbc.M113.528109 10.1016/j.ajpath.2013.07.015 10.1158/1078-0432.CCR-18-2752 10.1074/jbc.M110.117382 10.1038/nbt.2797 10.1158/1078-0432.CCR-15-1696 10.1093/abt/tbaa003 10.1016/j.bbrc.2007.02.042 10.1038/s41598-021-92320-x 10.1016/j.molimm.2015.02.033 10.1016/j.tips.2009.11.001 10.1182/blood-2016-08-735365 10.1016/j.pharmthera.2017.08.005 10.1016/j.jbiotec.2011.09.023 10.1016/0167-7799(91)90044-I 10.1093/abt/tbac012 10.1002/pro.3240 10.1007/s00262-010-0844-y 10.1080/19420862.2016.1268307 10.1016/j.csbj.2020.05.006 10.1186/s12896-016-0300-y 10.1016/S0022-2836(03)00526-6 10.2217/imt-2020-0256 10.3389/fimmu.2021.626616 10.1016/j.ymeth.2018.08.004 10.1126/science.2992089 10.1208/aapsj080359 10.1038/s41573-019-0028-1 10.1080/21645515.2018.1540828 |
ContentType | Journal Article |
Copyright | 2023 The Author(s). Published with license by Taylor & Francis Group, LLC. 2023 The Author(s) |
Copyright_xml | – notice: 2023 The Author(s). Published with license by Taylor & Francis Group, LLC. 2023 The Author(s) |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 5PM DOA |
DOI | 10.1080/19420862.2023.2231129 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic PubMed Central (Full Participant titles) Directory of Open Access Journals |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
DocumentTitleAlternate | H. P. LOH ET AL |
EISSN | 1942-0870 |
EndPage | 2231129 |
ExternalDocumentID | oai_doaj_org_article_8d90c44d609a46ee84e4e146feab623d 10_1080_19420862_2023_2231129 37403264 |
Genre | Journal Article |
GroupedDBID | --- 00X 0YH 4.4 53G ABCCY ABFIM ABPEM ACGFS ACTIO ADBBV ADCVX AEGYZ AEISY AENEX AIJEM ALMA_UNASSIGNED_HOLDINGS AOIJS AQRUH BABNJ BAWUL BLEHA C1A CCCUG CGR CUY CVF DGEBU DIK DKSSO E3Z EBS ECM EIF EJD EMOBN F5P GROUPED_DOAJ H13 HYE KTTOD KYCEM LJTGL M4Z NPM O9- OK1 OVD RPM SV3 TDBHL TEORI TFL TFT TFW TR2 TTHFI AAYXX CITATION 7X8 5PM |
ID | FETCH-LOGICAL-c478t-6d06232557a59e56af8cbc2a97b44781cb816fd743140969c1e65e44f6dc34c93 |
IEDL.DBID | RPM |
ISSN | 1942-0862 |
IngestDate | Tue Oct 22 15:16:40 EDT 2024 Tue Sep 17 21:30:20 EDT 2024 Wed Dec 04 16:02:11 EST 2024 Fri Dec 06 03:26:49 EST 2024 Wed Oct 16 00:39:51 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | avidity CHO cell bispecific antibody targeted integration thermal stability functionality manufacturability |
Language | English |
License | This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. The terms on which this article has been published allow the posting of the Accepted Manuscript in a repository by the author(s) or with their consent. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c478t-6d06232557a59e56af8cbc2a97b44781cb816fd743140969c1e65e44f6dc34c93 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Equal contribution. |
ORCID | 0000-0002-0026-7069 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10324450/ |
PMID | 37403264 |
PQID | 2833648736 |
PQPubID | 23479 |
PageCount | 1 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_8d90c44d609a46ee84e4e146feab623d pubmedcentral_primary_oai_pubmedcentral_nih_gov_10324450 proquest_miscellaneous_2833648736 crossref_primary_10_1080_19420862_2023_2231129 pubmed_primary_37403264 |
PublicationCentury | 2000 |
PublicationDate | 2023-00-00 |
PublicationDateYYYYMMDD | 2023-01-01 |
PublicationDate_xml | – year: 2023 text: 2023-00-00 |
PublicationDecade | 2020 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | mAbs |
PublicationTitleAlternate | MAbs |
PublicationYear | 2023 |
Publisher | Taylor & Francis Taylor & Francis Group |
Publisher_xml | – name: Taylor & Francis – name: Taylor & Francis Group |
References | e_1_3_5_29_1 e_1_3_5_27_1 e_1_3_5_25_1 e_1_3_5_23_1 e_1_3_5_44_1 e_1_3_5_67_1 e_1_3_5_46_1 e_1_3_5_48_1 e_1_3_5_3_1 e_1_3_5_61_1 e_1_3_5_40_1 e_1_3_5_63_1 e_1_3_5_42_1 e_1_3_5_65_1 e_1_3_5_9_1 e_1_3_5_21_1 e_1_3_5_5_1 e_1_3_5_7_1 e_1_3_5_18_1 e_1_3_5_39_1 e_1_3_5_16_1 e_1_3_5_37_1 e_1_3_5_35_1 e_1_3_5_12_1 e_1_3_5_33_1 e_1_3_5_56_1 e_1_3_5_58_1 e_1_3_5_50_1 e_1_3_5_52_1 e_1_3_5_54_1 e_1_3_5_10_1 e_1_3_5_31_1 e_1_3_5_28_1 e_1_3_5_26_1 e_1_3_5_24_1 e_1_3_5_22_1 e_1_3_5_45_1 e_1_3_5_66_1 e_1_3_5_47_1 e_1_3_5_68_1 e_1_3_5_49_1 e_1_3_5_2_1 e_1_3_5_60_1 e_1_3_5_41_1 e_1_3_5_62_1 e_1_3_5_43_1 e_1_3_5_64_1 e_1_3_5_8_1 e_1_3_5_20_1 e_1_3_5_4_1 e_1_3_5_6_1 e_1_3_5_17_1 e_1_3_5_38_1 e_1_3_5_15_1 e_1_3_5_13_1 e_1_3_5_36_1 e_1_3_5_11_1 e_1_3_5_34_1 e_1_3_5_55_1 e_1_3_5_57_1 e_1_3_5_59_1 e_1_3_5_19_1 e_1_3_5_51_1 e_1_3_5_53_1 e_1_3_5_32_1 e_1_3_5_30_1 |
References_xml | – ident: e_1_3_5_18_1 doi: 10.1074/jbc.M117.793497 – ident: e_1_3_5_42_1 doi: 10.1136/jitc-2021-003114 – ident: e_1_3_5_56_1 doi: 10.1016/j.ccell.2017.02.001 – ident: e_1_3_5_61_1 doi: 10.1021/bi00209a003 – ident: e_1_3_5_47_1 doi: 10.1016/S0006-3495(00)76602-1 – ident: e_1_3_5_50_1 doi: 10.1371/journal.pone.0051817 – ident: e_1_3_5_6_1 doi: 10.1016/S1470-2045(22)00335-7 – ident: e_1_3_5_12_1 doi: 10.1093/protein/gzp077 – ident: e_1_3_5_67_1 doi: 10.1093/abt/tbac025 – ident: e_1_3_5_55_1 doi: 10.3389/fcell.2019.00370 – ident: e_1_3_5_37_1 doi: 10.1016/j.ymeth.2018.08.008 – ident: e_1_3_5_20_1 doi: 10.1016/j.ymeth.2018.10.005 – ident: e_1_3_5_35_1 doi: 10.1016/j.ymeth.2018.10.006 – ident: e_1_3_5_25_1 doi: 10.1007/s13238-017-0429-z – ident: e_1_3_5_63_1 doi: 10.1371/journal.pone.0063247 – ident: e_1_3_5_28_1 doi: 10.1080/19420862.2019.1574521 – ident: e_1_3_5_7_1 doi: 10.1007/s40265-022-01793-1 – ident: e_1_3_5_11_1 doi: 10.2147/CPAA.S42689 – ident: e_1_3_5_29_1 doi: 10.1016/j.ymeth.2018.10.026 – ident: e_1_3_5_58_1 doi: 10.1080/2162402X.2016.1168557 – ident: e_1_3_5_9_1 doi: 10.1007/s40259-018-0299-9 – ident: e_1_3_5_52_1 doi: 10.1016/j.chroma.2019.04.012 – ident: e_1_3_5_38_1 doi: 10.4161/19420862.2015.989013 – ident: e_1_3_5_16_1 doi: 10.1093/protein/9.7.617 – ident: e_1_3_5_51_1 doi: 10.1016/j.drudis.2015.02.008 – ident: e_1_3_5_15_1 doi: 10.1186/s13045-015-0227-0 – ident: e_1_3_5_62_1 doi: 10.1002/biot.201700175 – ident: e_1_3_5_34_1 doi: 10.1155/2012/980250 – ident: e_1_3_5_54_1 doi: 10.1038/sj.bjc.6601759 – ident: e_1_3_5_30_1 doi: 10.1126/scitranslmed.aat5775 – ident: e_1_3_5_19_1 doi: 10.1074/jbc.M114.620260 – ident: e_1_3_5_23_1 doi: 10.1073/pnas.1019002108 – ident: e_1_3_5_36_1 doi: 10.1073/pnas.1719905115 – ident: e_1_3_5_13_1 doi: 10.1016/S1389-0344(01)00066-1 – ident: e_1_3_5_49_1 doi: 10.1002/jps.21104 – ident: e_1_3_5_39_1 doi: 10.1200/JCO.2020.38.6_suppl.TPS261 – ident: e_1_3_5_24_1 doi: 10.1074/jbc.M113.528109 – ident: e_1_3_5_60_1 doi: 10.1016/j.ajpath.2013.07.015 – ident: e_1_3_5_27_1 doi: 10.1158/1078-0432.CCR-18-2752 – ident: e_1_3_5_17_1 doi: 10.1074/jbc.M110.117382 – ident: e_1_3_5_21_1 doi: 10.1038/nbt.2797 – ident: e_1_3_5_31_1 doi: 10.1158/1078-0432.CCR-15-1696 – ident: e_1_3_5_3_1 doi: 10.1093/abt/tbaa003 – ident: e_1_3_5_48_1 doi: 10.1016/j.bbrc.2007.02.042 – ident: e_1_3_5_66_1 doi: 10.1038/s41598-021-92320-x – ident: e_1_3_5_4_1 doi: 10.1016/j.molimm.2015.02.033 – ident: e_1_3_5_46_1 doi: 10.1016/j.tips.2009.11.001 – ident: e_1_3_5_26_1 doi: 10.1182/blood-2016-08-735365 – ident: e_1_3_5_33_1 doi: 10.1016/j.pharmthera.2017.08.005 – ident: e_1_3_5_64_1 doi: 10.1016/j.jbiotec.2011.09.023 – ident: e_1_3_5_53_1 doi: 10.1016/0167-7799(91)90044-I – ident: e_1_3_5_68_1 doi: 10.1093/abt/tbac012 – ident: e_1_3_5_22_1 doi: 10.1002/pro.3240 – ident: e_1_3_5_57_1 doi: 10.1007/s00262-010-0844-y – ident: e_1_3_5_10_1 doi: 10.1080/19420862.2016.1268307 – ident: e_1_3_5_32_1 doi: 10.1016/j.csbj.2020.05.006 – ident: e_1_3_5_65_1 doi: 10.1186/s12896-016-0300-y – ident: e_1_3_5_59_1 doi: 10.1016/S0022-2836(03)00526-6 – ident: e_1_3_5_44_1 doi: 10.2217/imt-2020-0256 – ident: e_1_3_5_2_1 doi: 10.3389/fimmu.2021.626616 – ident: e_1_3_5_41_1 doi: 10.1016/j.ymeth.2018.08.004 – ident: e_1_3_5_43_1 doi: 10.1126/science.2992089 – ident: e_1_3_5_45_1 doi: 10.1208/aapsj080359 – ident: e_1_3_5_40_1 doi: 10.1038/s41573-019-0028-1 – ident: e_1_3_5_5_1 doi: 10.1080/21645515.2018.1540828 – ident: e_1_3_5_8_1 doi: 10.1016/j.pharmthera.2017.08.005 |
SSID | ssj0000070170 |
Score | 2.4000633 |
Snippet | T-cell-engaging bispecific antibodies (T-bsAbs) are promising immunotherapies for cancer treatment due to their capability of redirecting T-cells toward... ABSTRACTT-cell-engaging bispecific antibodies (T-bsAbs) are promising immunotherapies for cancer treatment due to their capability of redirecting T-cells... |
SourceID | doaj pubmedcentral proquest crossref pubmed |
SourceType | Open Website Open Access Repository Aggregation Database Index Database |
StartPage | 2231129 |
SubjectTerms | Antibodies, Bispecific avidity bispecific antibody CHO cell functionality Immunoglobulin Fab Fragments Immunoglobulin G manufacturability Single-Chain Antibodies T-Lymphocytes targeted integration |
SummonAdditionalLinks | – databaseName: Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1RT9swELYQT3tBsMEWNiYjoT6R4iQXx3lk0xBCAvWhSLxFtmOPSihFbfrQf7-7OCktmrSXvV6ixLmzfd9dfN8xdiHq1OIeqGKdqDIGnZex8Ri1lnlqhBW5TSzlO-4f5O0j3D3lT1utvuhMWKAHDoq7UnUpLEAtRalBOqfAgcPl7Z026LrrbvcV6VYwFYBvQcQw3S9lSGPC7UP5jhJXJCPRmHqHj9FBEujYcUwdf__fQOf7s5NbzujmkB30KJJfh9EfsT3XfGSjSaChXl_y6VtV1fKSj_jkjaB6_Ym93OtmRRUNq0Vg6V5z3dScXFzIDHaSDWUnn3s-9FFpeQC5SxJOY0r7c9f87lodcTOjuk06e4TPa2dmTicUj9njza_pz9u477oQWyhUG8taoF4x0ijQcC6X2itrbKrLwgDVpVqjEulrQh4YG8rSJk7mDsDL2mZgy-yE7Tfzxn1h3BoQuiBGLQzEXCaN9VmqEHMSa5z3PmLjQeXVayDXqJKes3SwUUU2qnobRewHGWZzM3FjdwKcMVU_Y6p_zZiInQ9mrXAtkaZ04-arZYVQK5MYwWUyYp-DmTevyvA7EOpCxNTOBNgZy-6VZvbc8XUTZyFALk7_x-i_sg-kkZAF-sb228XKnSEuas33bgn8AZeJCTo priority: 102 providerName: Directory of Open Access Journals |
Title | Manufacturability and functionality assessment of different formats of T-cell engaging bispecific antibodies |
URI | https://www.ncbi.nlm.nih.gov/pubmed/37403264 https://search.proquest.com/docview/2833648736 https://pubmed.ncbi.nlm.nih.gov/PMC10324450 https://doaj.org/article/8d90c44d609a46ee84e4e146feab623d |
Volume | 15 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwEB4Bh4pLVegrLUWuVHEi2Twcxzm2CISQttrDInGLbMemK0GCdrOH_fedcZKFrXriOkmcxDPOfDOZ-QzwI65Tg99AGapEliFXeRlqh1Frmac6NnFuEkP5julvcX3Lb-7yuz0QYy-ML9o3ehE1D49Rs_jjayufHs1krBObzKYXRALHeR5P9mEf_e-LGL0HvQWRwvjfyTwNCbOPrTsynpCMRBHtGx6hcyTAcQhvsoLjqILv-CdP4_8_7PlvCeULn3T1Dt4OYJL97B_6CPZscwxns56NenPO5s_NVatzdsZmzzzVm_fwMFXNmhob1suerHvDVFMz8nR9gtBLtsydrHVs3E6lYz3WXZFwHlL2n9nm3u94xPSC2jepBAnH6xa6pULFD3B7dTm_uA6HzRdCwwvZhaKOERlhwFGg_mwulJNGm1SVhebUnmq0TISrCYBgiChKk1iRW86dqE3GTZl9hIOmbexnYEbzWBVErIXxmM2ENi5LJUJPIo9zzgUQjVNePfUcG1UyUJeO6qpIXdWgrgB-kWK2JxNFthe0y_tqMJRK1mVsOK9FXCourJXccot-wVml8c3qAL6Paq1wSdFMqca261WFiCsTGMhlIoBPvZq3txrNJAC5YwA7z7J7BK3Y03aPVvvl9Zd-hUOahz4FdAIH3XJtvyEo6vSpTyac-pXwF7GKCmo |
link.rule.ids | 230,314,727,780,784,864,885,2102,4024,27923,27924,27925,53791,53793 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwEB5RKrVcUN8NLa0rVZxINg_HsY8FFW1bFu1hkbhZtmPTlSBBu9nD_vt68ljYihPXSeIknnHmm8nMZ4DvcZka_w3koUq4CKnKRaidj1pFnurYxLlJDOY7JhdsfEl_X-VXO8CGXpi2aN_oeVTd3EbV_G9bW3l3a0ZDndhoOjlFEjhK83j0DJ7nWSGSB1F6B3sLpIVpfyjTNETUPjTv8HiEMhRFuHN45N0jQo49eJEV1I_L6JaHaon8H0Of_xdRPvBKZ69gv4eT5Ef32K9hx1Zv4Gja8VGvj8nsvr1qeUyOyPSeqXr9Fm4mqlpha8Nq0dF1r4mqSoK-rksRtpINdyepHRk2VGlIh3aXKJyFmP8ntrpu9zwieo4NnFiE5Mdr5rrGUsV3cHn2c3Y6DvvtF0JDC96ErIw9NvIhR-E1aHOmHDfapEoUmmKDqtE8Ya5ECOKDRCZMYlluKXWsNBk1InsPu1Vd2Y9AjKaxKpBay0dkNmPauCzlHnwifZxzLoBomHJ517FsyKQnLx3UJVFdsldXACeomM3JSJLdCurFtexNRfJSxIbSksVCUWYtp5Za7xmcVdq_WRnAt0Gt0i8qnClV2Xq1lB5zZcyHchkL4EOn5s2tBjMJgG8ZwNazbB_xdtwSdw92e_D0S7_Cy_Fsci7Pf138-QR7OCddQugz7DaLlT30EKnRX9r18A-R0gzK |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9swDBa2Dih6Gfae99SAoafalm1Zlo9bt6B7pMghBXozJFlqA7RykDiH_PuRfqTNsNOutC3LImV-lMhPhHxmdWrgHyhDlcgy5CovQ-0gai3zVDPDcpMYXO-YnouzC_7zMr8csirXQ1qlN3oR-ZvbyC-uu9zK5a2JxzyxeDY9RRI4znMWL2sXPySP8gys7F6k3kPfAqlhuk1lnoaI3McCHslilKEowtPDI3CRCDuOyGFWcGhb8D0v1ZH5_wuB_p1Iec8zTZ6QxwOkpF_6rj8lD6x_Ro5nPSf19oTO70qs1if0mM7u2Kq3z8nNVPkNljdsVj1l95YqX1P0d_0yYSfZ8XfSxtHxUJWW9oh3jcJ5iHsA1Pqr7twjqhdYxImJSNBeu9ANpiu-IBeT7_PTs3A4giE0vJBtKGoG-AjCjgK0aHOhnDTapKosNMciVaNlIlyNMAQCRVGaxIrccu5EbTJuyuwlOfCNt68JNZozVSC9FkRlNhPauCyVAECRQs45F5BoHPJq2TNtVMlAYDqqq0J1VYO6AvIVFbO7GYmyO0GzuqoGc6lkXTLDeS1YqbiwVnLLLXgHZ5WGL6sD8mlUawUTC0dKedts1hXgrkxAOJeJgLzq1bx71WgmAZF7BrDXl_0rYMsdefdou2_-_9GP5HD2bVL9_nH-6y05wiHp14TekYN2tbHvASW1-kM3Hf4AdNQN3Q |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Manufacturability+and+functionality+assessment+of+different+formats+of+T-cell+engaging+bispecific+antibodies&rft.jtitle=mAbs&rft.au=Loh%2C+Han+Ping&rft.au=Mahfut%2C+Farouq+Bin&rft.au=Chen%2C+Serene+W&rft.au=Huang%2C+Yuhan&rft.date=2023&rft.pub=Taylor+%26+Francis&rft.issn=1942-0862&rft.eissn=1942-0870&rft.volume=15&rft.issue=1&rft_id=info:doi/10.1080%2F19420862.2023.2231129&rft_id=info%3Apmid%2F37403264&rft.externalDBID=PMC10324450 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1942-0862&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1942-0862&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1942-0862&client=summon |